Literature DB >> 1579132

Cholesterol alterations in young dystrophic mice.

D M Logan1, K H Tsang.   

Abstract

Cholesterol and cholesteryl ester concentrations and cholesteryl ester fatty acid substituents have been measured during the first 10 weeks of life in tissues of normal and dystrophic mice. In normal Swiss and 129ReJ(+/?) mice the concentrations of both cholesterol and cholesteryl esters remain essentially constant in liver, increase in brain and fall sharply in both thigh (mixed fiber type muscles) and chest muscles (predominantly slow oxidative muscles) over this period. In all cases the concentration of free cholesterol exceeds that of esterified cholesterol. In dystrophic mice, similar patterns are found in brain and liver. In both thigh and chest muscles, however, the developmental pattern is significantly different. After an initial decrease the concentrations of cholesterol and cholesteryl esters increase rapidly with the largest increase occurring in the concentration of cholesteryl esters which by 10 weeks of age exceeds the concentration of cholesterol in chest muscle. During the same period the pattern of esterified fatty acids changes gradually in dystrophic tissues towards an increasing ratio of unsaturated/saturated fatty acids. By 10 weeks of age this ratio is significantly higher in dystrophic tissues than normal in all tissues tested.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1579132     DOI: 10.1007/bf02385006

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Abnormalities in membrane microviscosity and ion transport in genetic muscular dystrophy.

Authors:  R I Sha'afi; S B Rodan; R L Hintz; S M Fernandez; G A Rodan
Journal:  Nature       Date:  1975-04-10       Impact factor: 49.962

2.  Determination of cholesterol using o-phthalaldehyde.

Authors:  L L Rudel; M D Morris
Journal:  J Lipid Res       Date:  1973-05       Impact factor: 5.922

3.  Dysmyelination in the sciatic nerves of dystrophic mice.

Authors:  E Okada; V Mizuhira; H Nakamura
Journal:  J Neurol Sci       Date:  1976-08       Impact factor: 3.181

4.  Elevated cholesterol in tissues of chicken embryos with hereditary myotonic muscular dystrophy.

Authors:  P A Stewart; E S Werstiuk; J D Vickers; M P Rathbone
Journal:  Exp Neurol       Date:  1977-11       Impact factor: 5.330

Review 5.  Brain sterol metabolism.

Authors:  A N Davison
Journal:  Adv Lipid Res       Date:  1965

6.  Lipids of dystrophic and normal mouse muscle: whole tissue and particulate fractions.

Authors:  K Owens; B P Hughes
Journal:  J Lipid Res       Date:  1970-09       Impact factor: 5.922

7.  Increased membrane permeability to chloride in Duchenne muscular dystrophy fibroblasts and its relationship to muscle function.

Authors:  C N Pato; M H Davis; M J Doughty; S H Bryant; E Gruenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

8.  Skeletal muscle lipids in normal and dystrophic mice.

Authors:  P H Pearce; B A Kakulas
Journal:  Aust J Exp Biol Med Sci       Date:  1980-08

9.  Lipid changes in Duchenne muscular dystrophy.

Authors:  B P Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-10       Impact factor: 10.154

10.  Lipid composition of sarcoplasmic reticulum from mice with muscular dystrophy.

Authors:  R E Mrak; S Fleischer
Journal:  Muscle Nerve       Date:  1982 Jul-Aug       Impact factor: 3.217

View more
  2 in total

1.  Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.

Authors:  Stephanie L Sellers; Nadia Milad; Zoe White; Chris Pascoe; Rayleigh Chan; Geoffrey W Payne; Chun Seow; Fabio Rossi; Michael A Seidman; Pascal Bernatchez
Journal:  J Lipid Res       Date:  2017-11-25       Impact factor: 5.922

2.  Lipid mapping in human dystrophic muscle by cluster-time-of-flight secondary ion mass spectrometry imaging.

Authors:  Nora Tahallah; Alain Brunelle; Sabine De La Porte; Olivier Laprévote
Journal:  J Lipid Res       Date:  2007-11-17       Impact factor: 5.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.